attachment
attachment

Explain ?

Reading File
Finding Sources
Finding Sources
I have enough context from the image and the library. Here is a full explanation of all the lab results shown in the clinical notes:

Lab Report Explanation - COVID-19 Positive Patient

The patient has tested COVID RAT - Positive. Here is what each result means:

Inflammatory Markers

TestValueNormal RangeInterpretation
Sr. Ferritin125.64 ng/mL12-150 (F) / 12-300 (M) ng/mLHigh-normal to mildly elevated. Ferritin is an acute-phase reactant that rises in COVID-19 due to macrophage activation and inflammation.
CRP54.06 mg/L<5 mg/LSignificantly elevated. C-Reactive Protein is a key marker of acute inflammation. A value >10 mg/L indicates active inflammation; 54 is markedly elevated, consistent with moderate COVID-19 inflammatory response.
D-Dimer1800 ng/mL (or µg/L)<500 ng/mLCritically elevated (3.6x normal). D-Dimer is a fibrin degradation product indicating clot formation and breakdown. This high value in COVID-19 signals a significant coagulopathy / thrombotic risk, which is a hallmark of moderate-to-severe COVID-19. The risk of DVT, pulmonary embolism, or microthrombi is elevated.
Key concern: Elevated D-Dimer + elevated CRP together in COVID-19 indicates hyperinflammation with coagulopathy - a known serious complication.

Thyroid Function Tests

TestValueNormal RangeInterpretation
T31.5 ng/mL0.8-2.0 ng/mLNormal
T40.94 ng/dL0.8-1.8 ng/dLNormal
TSH1.66 mIU/L0.4-4.0 mIU/LNormal
Thyroid function is entirely within normal limits. No thyroid disease.

Vitamins & Minerals

TestValueNormal RangeInterpretation
Vitamin D67.6 ng/mL30-100 ng/mLNormal / Sufficient. (>30 is sufficient; >50 is optimal). Good vitamin D status, which is actually protective in respiratory infections.
B127128 pg/mL200-900 pg/mLVery elevated. Likely due to recent B12 supplementation/injection. Can also be elevated in liver disease or myeloproliferative disorders, but supplementation is the most common cause.
Calcium (Ca+)8.34 mg/dL8.5-10.5 mg/dLBorderline low-normal. Slightly below reference range. Hypocalcemia is commonly seen in COVID-19.
Magnesium (Mg)2.15 mg/dL1.7-2.2 mg/dLNormal

Electrolytes

TestValueNormal RangeInterpretation
Sodium (Na)134 mEq/L136-145 mEq/LMildly low (mild hyponatremia). Common in COVID-19, often from SIADH (syndrome of inappropriate ADH secretion) or poor oral intake.
Potassium (K)4.3 mEq/L3.5-5.0 mEq/LNormal
Chloride (Cl)101 mEq/L98-107 mEq/LNormal

Kidney Function

TestValueNormal RangeInterpretation
Creatinine (Creat)1.34 mg/dL0.6-1.1 (F) / 0.7-1.3 (M) mg/dLMildly elevated. Suggests mild renal impairment. Acute kidney injury (AKI) is a known complication of COVID-19 due to direct viral injury to renal tubules and ischemia.

Complete Blood Count (CBC)

TestValueNormal RangeInterpretation
Hb (Hemoglobin)10.5 g/dL12-16 (F) / 13-17 (M) g/dLLow - Anemia. Mild-to-moderate anemia. COVID-19 can cause anemia through inflammation (anemia of chronic disease) or direct bone marrow suppression.
TC (Total Count / WBC)11,120 /µL4,000-11,000 /µLMildly elevated (leukocytosis). Just above normal. Could suggest a secondary bacterial superinfection or a stress response. Note: COVID-19 classically causes leukopenia (low WBC), so leukocytosis here warrants attention for secondary infection.
Plt (Platelets)217,000 /µL150,000-400,000 /µLNormal

Overall Clinical Picture

This patient has confirmed COVID-19 with the following concerning features:
  1. High D-Dimer (1800) - significant thrombotic risk; anticoagulation should be considered
  2. High CRP (54) - moderate-to-severe inflammatory response ("cytokine storm" spectrum)
  3. Mild anemia (Hb 10.5) - likely COVID-related
  4. Mild renal impairment (Creat 1.34) - monitor for AKI progression
  5. Mild hyponatremia (Na 134) - likely COVID-related SIADH
  6. Borderline low calcium - common in COVID
  7. Leukocytosis - rule out secondary bacterial infection
The D-Dimer and CRP elevation together suggest this patient likely has moderate COVID-19 and is at risk for thromboembolic complications. Close monitoring, anticoagulation assessment, and fluid/electrolyte management would typically be priorities.
This is a shared conversation. Sign in to Orris to start your own chat.